Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis

Gastroenterology

Volumn 150, Issue 1, 2016, Pages 194-205

  Xia, Yuchen ^a   Stadler, Daniela ^a   Lucifora, Julie ^a,g   Reisinger, Florian ^a   Webb, Dennis ^b   Hösel, Marianna ^b   Michler, Thomas ^a   Wisskirchen, Karin ^a,g   Cheng, Xiaoming ^a   Zhang, Ke ^a   Chou, Wen Min ^a   Wettengel, Jochen M ^a   Malo, Antje ^a   Bohne, Felix ^a   Hoffmann, Dieter ^a   Eyer, Florian ^c   Thimme, Robert ^d   Falk, Christine S ^e,g   Thasler, Wolfgang E ^f   Heikenwalder, Mathias ^a   Protzer, Ulrike ^a,g   more..

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^g DZHK (German Centre for Cardiovascular Research)   (Germany)

Author keywords

Apolipoprotein B mRNA Editing Enzyme; HBV Persistence; Immune Regulation; T Cell Receptor

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3A; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3B; CASPASE 3; CCL1 CHEMOKINE; CIRCULAR DNA; COVALENTLY CLOSED CIRCULAR DNA; ENTECAVIR; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; INTERLEUKIN 13; INTERLEUKIN 5; LACTATE DEHYDROGENASE; LAMIVUDINE; MESSENGER RNA; MITOCHONDRIAL DNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIVIRUS AGENT; VIRUS DNA;

ACUTE HEPATITIS B; ARTICLE; BLOOD SAMPLING; CHRONIC HEPATITIS B; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOLYSIS; DEAMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; IN VITRO STUDY; LIVER BIOPSY; LIVER CELL; PRIORITY JOURNAL; T LYMPHOCYTE; VIRAL CLEARANCE; VIRUS REPLICATION; CELL CULTURE; COCULTURE; COMPARATIVE STUDY; DNA REPLICATION; DRUG EFFECTS; HEPACIVIRUS; HEPATITIS B; HEPG2 CELL LINE; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; VIRUS LOAD;

ANTIVIRAL AGENTS; CELLS, CULTURED; COCULTURE TECHNIQUES; DNA REPLICATION; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEP G2 CELLS; HEPACIVIRUS; HEPATITIS B; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-GAMMA; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; VIRAL LOAD; VIRUS REPLICATION;

EID: 84952684286     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.09.026     Document Type: Article

References (38)

1. U. Protzer, M.K. Maini, and P.A. Knolle Living in the liver: hepatic infections Nat Rev Immunol 12 2012 201 213
2. L.G. Guidotti, K. Ando, M.V. Hobbs, and et al. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice Proc Natl Acad Sci U S A 91 1994 3764 3768
3. H. McClary, R. Koch, F.V. Chisari, and et al. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines J Virol 74 2000 2255 2264
4. D. Wohlleber, H. Kashkar, K. Gartner, and et al. TNF-induced target cell killing by CTL activated through cross-presentation Cell Rep 2 2012 478 487
5. G. Ebert, S. Preston, C. Allison, and et al. Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus Proc Natl Acad Sci U S A 112 2015 5797 5802
6. S. Phillips, S. Chokshi, A. Riva, and et al. CD8(+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions J Immunol 184 2010 287 295
7. L.G. Guidotti, R. Rochford, J. Chung, and et al. Viral clearance without destruction of infected cells during acute HBV infection Science 284 1999 825 829
8. S.F. Wieland, H.C. Spangenberg, R. Thimme, and et al. Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees Proc Natl Acad Sci U S A 101 2004 2129 2134
9. R. Thimme, S. Wieland, C. Steiger, and et al. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection J Virol 77 2003 68 76
10. J. Summers, A.R. Jilbert, W. Yang, and et al. Hepatocyte turnover during resolution of a transient hepadnaviral infection Proc Natl Acad Sci U S A 100 2003 11652 11659
11. F. Liu, M. Campagna, Y. Qi, and et al. Alpha-interferon suppresses hepadnavirus transcription by altering epigenetic modification of cccDNA minichromosomes PLoS Pathog 9 2013 e1003613
12. J. Lucifora, Y. Xia, F. Reisinger, and et al. Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA Science 343 2014 1221 1228
13. J. Lucifora, S. Arzberger, D. Durantel, and et al. Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection J Hepatol 55 2011 996 1003
14. W.E. Thasler, T.S. Weiss, K. Schillhorn, and et al. Charitable state-controlled foundation human tissue and cell research: ethic and legal aspects in the supply of surgically removed human tissue for research in the academic and commercial sector in Germany Cell Tissue Bank 4 2003 49 56
15. S. Jost, P. Turelli, B. Mangeat, and et al. Induction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferons J Virol 81 2007 10588 10596
16. O. Hantz, R. Parent, D. Durantel, and et al. Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells J Gen Virol 90 2009 127 135
17. D. Glebe, M. Aliakbari, P. Krass, and et al. Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus J Virol 77 2003 9511 9521
18. A. Untergasser, U. Zedler, A. Langenkamp, and et al. Dendritic cells take up viral antigens but do not support the early steps of hepatitis B virus infection Hepatology 43 2006 539 547
19. G. Ebert, C. Allison, S. Preston, and et al. Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosis Proc Natl Acad Sci U S A 112 2015 5803 5808
20. R. Suspene, D. Guetard, M. Henry, and et al. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo Proc Natl Acad Sci U S A 102 2005 8321 8326
21. H.E. Krokan, and M. Bjoras Base excision repair Cold Spring Harb Perspect Biol 5 2013 a012583
22. F. Bohne, M. Chmielewski, G. Ebert, and et al. T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes Gastroenterology 134 2008 239 247
23. K. Krebs, N. Bottinger, L.R. Huang, and et al. T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice Gastroenterology 145 2013 456 465
24. A. Lanzavecchia, and F. Sallusto Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells Science 290 2000 92 97
25. D. Dimitropoulou, M. Karakantza, G.L. Theodorou, and et al. Serum cytokine profile in patients with hepatitis B e antigen-negative chronic active hepatitis B and inactive hepatitis B virus carriers World J Gastrointest Pathophysiol 4 2013 24 27
26. Z. Ben-Ari, E. Mor, O. Papo, and et al. Cytokine gene polymorphisms in patients infected with hepatitis B virus Am J Gastroenterol 98 2003 144 150
27. S. Qi, B. Cao, M. Jiang, and et al. Association of the -183 polymorphism in the IFN-gamma gene promoter with hepatitis B virus infection in the Chinese population J Clin Lab Anal 19 2005 276 281
28. Y.J. Kim, H.S. Lee, J.H. Yoon, and et al. Association of TNF-alpha promoter polymorphisms with the clearance of hepatitis B virus infection Hum Mol Genet 12 2003 2541 2546
29. M.H. Zheng, D.D. Xiao, X.F. Lin, and et al. The tumour necrosis factor-alpha-238A allele increases the risk of chronic HBV infection in European populations J Viral Hepat 19 2012 e11 e17
30. C.H. Roux, O. Brocq, V. Breuil, and et al. Safety of anti-TNF-alpha therapy in rheumatoid arthritis and spondylarthropathies with concurrent B or C chronic hepatitis Rheumatology (Oxford) 45 2006 1294 1297
31. E. Feduchi, M.A. Alonso, and L. Carrasco Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus J Virol 63 1989 1354 1359
32. P. Lucin, S. Jonjic, M. Messerle, and et al. Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor J Gen Virol 75 1994 101 110
33. S.F. Wieland, A. Eustaquio, C. Whitten-Bauer, and et al. Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids Proc Natl Acad Sci U S A 102 2005 9913 9917
34. V. Pasquetto, S.F. Wieland, S.L. Uprichard, and et al. Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures J Virol 76 2002 5646 5653
35. C. Xu, H. Guo, X.B. Pan, and et al. Interferons accelerate decay of replication-competent nucleocapsids of hepatitis B virus J Virol 84 2010 9332 9340
36. M. Biermer, R. Puro, and R.J. Schneider Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid integrity through activation of NF-kappaB J Virol 77 2003 4033 4042
37. M. Bonvin, F. Achermann, I. Greeve, and et al. Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication Hepatology 43 2006 1364 1374
38. H.V. Mehta, P.H. Jones, J.P. Weiss, and et al. IFN-alpha and lipopolysaccharide upregulate APOBEC3 mRNA through different signaling pathways J Immunol 189 2012 4088 4103